Giallongo, A.; Parisi, G.F.; Papale, M.; Manti, S.; Mulé, E.; Aloisio, D.; Terlizzi, V.; Rotolo, N.; Leonardi, S.
Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease. Genes 2023, 14, 449.
https://doi.org/10.3390/genes14020449
AMA Style
Giallongo A, Parisi GF, Papale M, Manti S, Mulé E, Aloisio D, Terlizzi V, Rotolo N, Leonardi S.
Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease. Genes. 2023; 14(2):449.
https://doi.org/10.3390/genes14020449
Chicago/Turabian Style
Giallongo, Alessandro, Giuseppe Fabio Parisi, Maria Papale, Sara Manti, Enza Mulé, Donatella Aloisio, Vito Terlizzi, Novella Rotolo, and Salvatore Leonardi.
2023. "Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease" Genes 14, no. 2: 449.
https://doi.org/10.3390/genes14020449
APA Style
Giallongo, A., Parisi, G. F., Papale, M., Manti, S., Mulé, E., Aloisio, D., Terlizzi, V., Rotolo, N., & Leonardi, S.
(2023). Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease. Genes, 14(2), 449.
https://doi.org/10.3390/genes14020449
